ArticleNature medicine2026
Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.
Sibylle Loibl et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleNature medicine2026
Sibylle Loibl et al.PubMed ↗Publisher ↗
No numbers read from the abstract.